Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
66 Cards in this Set
- Front
- Back
What are the statins to know?
|
Lovastatin and Simvastatin
|
|
How do lovastatin and simvastatin produce their effects
|
HMG CoA reductase inhibitors
|
|
What metabolic path are statins metabolized by?
|
CYP3A4 metabolism
|
|
What are the HMG CoA reductase inhibitors?
|
lovastatin and simvastatin
|
|
When do you use lovastatin and simvastatin? What does it do
|
1) 1st line of defense against hypercholesterolemia, at risk for mi
2) decreases TG , LDL (20-55%), increases HDL (5 -10%) 3) upregulates LDL receptors 4) stabilizes plaques |
|
What is the bile acid binding resin drug?
|
Cholestyramine
|
|
What is the mechanism of action of cholestyramine?
|
Cholestyramine is a bile acid binding resin -> binds bile and prevents its reabsorption. Reduced bile amounts causes increased conversion of cholesterol to bile. LDL receptor number is increased as a compensatory reaction
|
|
Which drug works via: binding bile and preventing its reabsorption, causing increased conversion of cholesterol to bile
|
Cholestyramine
|
|
What drug treats elevated cholesterol, esecially LDL concentrations that are elevated due to poor diet
|
Cholestyramine
|
|
What change in the lipid profile do you see when examining cholestyramine
|
HDL increases 4-5%
LDL decreaess 12-25% TGs increase (transiently if the person has normal TG; significant if they have high TGs) |
|
What is the contraindication for cholestyramine?
|
People with high TGs should not take cholestyramine. Cholestyramine can raise TG levels
|
|
Which drug should not be taken in people with high TGs?
|
Cholestyramine
|
|
What is the mechanism of action of niacin/nicotinic acid?
|
Decreases VLDL/TG synthesis
Inhibits FFA mobilization Inhibits uptake of HDL-apoA1 (increased plasma HDL) |
|
Which drug decreases VLDL/TG synthesis, inhibits FFA mobilization, and inhibits uptake of HDL-apoA1
|
Nicotinic acid/niacin
|
|
What drug is indicated for reducing TGs 35-50%, LDL 25%, and HDL up 15-30%
|
Nicotinic acid
|
|
What effects does nicotinic acid have on the lipid profile?
|
TG reduced 35-50%
LDL reduced 25% HDL increased 15-30% |
|
What drug in combination with statins can cause myopathy?
|
Niacin
|
|
What is niacin used to treat?
|
Hypertriglyceridemia and elevated LDL
|
|
How do fibric acids/gemfibrozil work?
|
PPAR activators.
This decreases FA synthesis Increases Beta oxidation Increases HDL Increases LDL size |
|
What drugs are PPAR activators, in turn decreasing FA synthesis, Increasing beta oxidation, increasing HDL, increasing LDL size
|
Fibric acids
Gemfibrozil |
|
What is the clinical use of fibrates/gemfibrozil?
|
High TGs (>750 mg/dl)
or treat HIgh TG and Low LDL (metabolic syndrome/type 2 diabetes) |
|
What drug treats extremely high TG levels
or high TG levels and low LDL (seen in metabolic syndrome /type 2 diabetes) |
Fibric acids/ gemfibrozil
|
|
What is the lipid profile of someone who takes gemfibrozil/fibric acids
|
TGS down 30-50%
LDL down15-20% Increased HDL 5-15% |
|
Which drug causes
TGS down 30-50% LDL down 15-20% Increased HDL 5-15% |
Fibric acids/gemfibrozil
|
|
How does ezetimibe work?
|
Inhibits NPCl1 (niemann pick cl like 1 protein), which results in reduced uptake of cholesterol from lumen.
|
|
Which drug inhibits NPCl1 (niemann pick cl like 1 protein) which results in decreased uptake of cholesterol from the lumen
|
Ezetimibe
|
|
What is ezetimibe combined with for therapy?
|
Statins or fibrates
|
|
What is the lipid profile of someone who takes ezetimibe
|
TG down 5%
LDL down 15-20% HDL up 1-2% |
|
If TG goes down 5%
LDL down 15-20% HDL up 1-2% which drug did they take |
Ezetimibe
|
|
Who do you give ezetimibe to?
|
Those who are resistant to statins
or combine with statins to really reduce LDL 60% |
|
What drug is given to those who are resistant to statins or combined with statins to really reduce LDL 60%
|
Ezetimibe
|
|
What does heparin treat
|
initial treatment of DVT
initial treatment of unstable angina/mi |
|
Which drug is used for initial treatment of DVT, initial treatment of mi/unstable angina
|
Heparin
|
|
What is the mechanism of action of heparin
|
Heparin binds and potentiates antithrombin III, which inhibits coagulation factors ii, ixa, xa.
|
|
Which drug binds and potentiates antithrombin III, inhibiting coagulation factors II, IXa, Xa?
|
Heparin
|
|
What does enoxaparin/dalteparin treat?
|
Acute DVT
Acute Unstable angina MI Hip replacement surgery |
|
Which drug could you give that treats acute DVT, acute Unstable MI, used in hip replacement surgery
|
enoxaparin
dalteparin |
|
What is the mechanism of action of enoxaparin/dalteparin?
|
Binds and potentiates antithrombin III just like heparin, but inhibits factor Xa much more.
|
|
Which drug is low molecular weight heparin?
|
Enoxaparin
Dalteparin |
|
Which drug binds and potentiates antithrombin III, but inhibits factor Xa much more
|
Enoxaparin
Dalteparin |
|
What is protamine sulfate used for?
|
To reverse heparin after cardiopulmonary bypass
|
|
Which drug is used to reverse heparin after cardiopulmonary bypass?
|
Protamine sulfate
|
|
What is the mechanism of action of protamine sulfate?
|
Binds heparin and forms inactive complex.
Protamine = positively charged. |
|
Which drug is positively charged and forms an inactive complex with heparin to inactivate it
|
Protamine sulfate
|
|
What is warfarin used to treat?
|
Long term treatment of venous thromboembolism disease
Prophylaxis against thromboembolism in patients with a fib, dilated cardiomyopathy, and prosthetic heart valves |
|
Which drug is used to treat venous thromboembolism disease as well as prophylaxis in patients with a fib, dilated cardiomyopathy, or prosthetic valves against thromboembolism
|
Warfarin
|
|
What is the mechanism of warfarin?
|
Vitamin k epoxide reductase inhibitor -> no activation of factors 2, 7, 9, 10
|
|
Which drug is a vitamin k epoxide reductase inhibitor -> no activation of factors 2, 7, 9, 10
|
Warfarin
|
|
What is dabigatran used to treat?
|
Thrombophylaxis in patients undergoing knee/hip surgery
Reduce risk of stroke and systemic embolism in ptnts with Afib |
|
What drug is used for thromboprophylaxis in patients who have undergone knee or hip replacement procedures
and for prevention of stroke and systemic embolism in patients with afib? |
Rivaroxaban and Dabigatran
|
|
What is the mechanism of action of dabigatran
|
Binds and inhibits thrombin to prevent thrombin induced platelet aggregation.
|
|
What drug binds and inhibits thrombin to prevent thrombin induced platelet aggregation
|
Dabigatran
|
|
What is the mechanism of action of rivaroxaban?
|
Reversible binding with factor Xa
|
|
What is rivaroxaban used to treat?
|
Thrombophylaxis in patients who underwent hip/knee surgery
Reduce risk of stroke and systemic embolism in patients with a fib |
|
What is lepirudin used to treat?
|
Lepirudin is used to treat heparin induced thrombocytopenia
|
|
What drug treats heparin induced thrombocytopenia
|
Lepirudin
|
|
What is the mechanism of action of lepirudin?
|
Lepirudin is a thrombin inhibitor
|
|
Which drug is a thrombin inhibitor
|
Dabigatran and lepirudin
|
|
What is tissue plasminogen activator used for/atleplase?
|
Acute MI, stroke, DVT
|
|
What drug is used for acute mi, stroke, dvt?
|
Tissue plasminogen activator/atleplase
|
|
What is the mechanism for tissue plasminogen activator/atlepase?
|
Activates fibrin bound plasminogen. Plasmin degrades fibrin clots
|
|
Which drug activates fibrin bound plasminogen. Plasmin degrades fibrin clots.
|
Tissue plasminogen activator/atleplase
|
|
What is aminocaproic acid used for?
|
Procoagulant - reduce hemorrhage in surgery. Reduce Urinary tract bleeding.
|
|
Which drug is a procoagulant that reduces hemorrhage in surgery and reduces ut bleeding
|
aminocaproic acid
|
|
How does aminocaproic acid work
|
competitive inhibitor of plasminogen-fibrin
|
|
Which drug is a competitive inhibitor of plasminogen-fibrin
|
Aminocaproic acid
|